Six-year follow-up after successful triple therapy for helicobacter pylori infection in patients with peptic ulcer disease

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 10, 2001, Pages 1235-1239

  Van Der Wouden, E J ^a,b   Thijs, Jacob C ^b   Zwet, Anton A van ^b   Kleibeuker, Jan H ^c  

^a ISALA HOSPITAL   (Netherlands)

^b Bethesda Hospital   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Follow up; Helicobacter pylori; Peptic ulcer disease; Serology; Triple therapy

Indexed keywords

BISMUTH CITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; TETRACYCLINE;

ADULT; ARTICLE; BREATH ANALYSIS; ENDOSCOPY; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT DISEASE; SYMPTOM; UREA BREATH TEST;

AGED; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER; QUALITY OF LIFE; RECURRENCE; RETROSPECTIVE STUDIES; TETRACYCLINE; TREATMENT OUTCOME;

EID: 0034765842     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200110000-00018     Document Type: Article

References (29)

1. The European Helicobacter pylori study group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 1997; 41: 8-13.
2. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.
3. Forbes GM, Glaser ME, Cullen DJE, Warren JR, Cristiansen KJ, Marshall BJ. et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 258-260.
4. Borody T, Andrews P, Mancuso N, Jankiewicz E, Brandl S. Helicobacter pylori reinfection 4 years post-eradication. Lancet 1992; 339: 1295.1295.
5. Borody TJ, Andrews P, Mancuso N, McCauley D, Jankiewicz E, Ferch N. et al. Helicobacter pylori reinfection rate in patients with cured duodenal ulcer. Am J Gastroenterol 1994; 89: 529-532.
6. Abu-Mahfouz MZ, Prasad VM, Santograde P, Cutler AF. Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States. Am J Gastroenterol 1997; 92: 2025-2028.
7. Bell GD, Powell KU, Burridge SM, Harrison G, Rameh B, Weil J. et al. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med 1993; 86: 375-382.
8. Miehlke S, Bayerdorffer E, Lehn N, Meining A, Baestlein E, Mannes GA. et al. Helicobacter pylori reinfection in duodenal and gastric ulcer patients after antibacterial treatment [Abstract]. Gut 1995; 37 (suppl 1): 54.54.
9. Wilhelmsen I, Berstad A. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol 1994; 29: 874-879.
10. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K. et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-312.
11. Schutze K, Hentschel E, Brandstatter G. More on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 1356.1356.
12. Van der Hulst RWM, Rauws EAJ, Koycu B, Keller JJ, Bruno MJ, Tijssen JGP. et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori. Gastroenterology 1998; 113: 1082-1086.
13. Xia HX, Talley NJ, Keane CT, O’Morain C. Recurrence of Helicobacter pylori infection after successful eradication. Nature and possible causes. Dig Dis Sci 1997; 42: 1821-1834.
14. Schütze K, Hentschel E, Dragonics B, Hirschl AM. Helicobacter pylori reinfection with identical organisms: transmission by the patients’ spouses. Gut 1995; 36: 831-833.
15. Xia HX, Windle HJ, Marshall DG, Smyth CJ, Keane CT, O’Morain C. Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting. Gut 1995; 37: 30-34.
16. Hua J, Birac C, Xia H, O’Morain C, Glupczynski Y, Burette A. et al. Differentiation of recrudescence and reinfection during relapse of Helicobacter pylori infection [Abstract]. Am J Gastroenterol 1994; 89: 1295.1295.
17. Fendrick AM, Chey WD, Margaret N, Palaniappan J, Fennerty MB. Symptom status and the desire for Helicobacter pylori confirmatory testing after eradication therapy in patients with peptic ulcer disease. Am J Med 1999; 107: 133-136.
18. Bretange JF, Caekaert A, Barthelemy P, Heysone. The course of symptoms after Helicobacter pylori (H. p.): a one-year follow-up of a cohort of 258 patients with duodenal ulcer (DU) or non-ulcer dyspepsia (NUD) [Abstract]. Gastroenterology 1998; 114: A81.A81.
19. McColl KE, Dickson A, El-Nujumi A, El-Omar E, Kelman A. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease. Am J Gastroenterol 2000; 95: 101-105.
20. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-1447.
21. Thijs JC, Van Zwet AA, Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993; 28: 934-938.
22. Van der Zee KI, Sanderman R, Heyink JW, de Haas H. Psychometric qualities of the RAND 36-item Health Survey 1. 0: a multidimensional measure of general health status. Int J Behavioral Med 1996; 3: 104-122.
23. Van der Zee KI, Sanderman R, Heyink J. A comparison of two multidimensional measures of health status: the Nottingham health profile and the RAND 36-item health survey 1. 0. Quality of Life Research 1996; 5: 165-174.
24. Thijs JC, Van Zwet AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F. et al. Diagnostic tests for H. pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol 1996; 91: 2125-2129.
25. 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 603-607.
26. Kuipers EJ, Thijs JC, Festen HPM. Helicobacter pylori and peptic ulcer disease. Aliment Pharmacol Ther 1995; 9 (suppl 2): 59-69.
27. Braden B, Caspary WF, Lembcke B. Density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms. Dig Dis Sci 1997; 42: 2120-2123.
28. Hurenkamp GJB, Grundmeijer HGLM, Bindels PJE, Tytgat GNJ, van der Hulst RWM. Chronic use of stomach acid inhibitor medication in family practice in the region of Amsterdam. Ned Tijdschr Geneesk 1999; 143: 410-413
29. Cutler AF, Prasad VM, Santograde P. Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am J Med 1998; 105: 18-20.